Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: A double-blind, randomised, placebo-controlled test-of-concept phase 2b study

Glenda E. Gray*, Mary Allen, Zoe Moodie, Gavin Churchyard, Linda Gail Bekker, Maphoshane Nchabeleng, Koleka Mlisana, Barbara Metch, Guy de Bruyn, Mary H. Latka, Surita Roux, Matsontso Mathebula, Nivashnee Naicker, Constance Ducar, Donald K. Carter, Adrien Puren, Niles Eaton, M. Julie McElrath, Michael Robertson, Lawrence CoreyJames G. Kublin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

307 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: A double-blind, randomised, placebo-controlled test-of-concept phase 2b study'. Together they form a unique fingerprint.

Medicine & Life Sciences